Kebreten F. Manaye to Disease Models, Animal
This is a "connection" page, showing publications Kebreten F. Manaye has written about Disease Models, Animal.
Connection Strength
0.441
-
Manaye KF, Mouton PR, Xu G, Drew A, Lei DL, Sharma Y, Rebeck GW, Turner S. Age-related loss of noradrenergic neurons in the brains of triple transgenic mice. Age (Dordr). 2013 Feb; 35(1):139-47.
Score: 0.073
-
Kalifa S, Polston EK, Allard JS, Manaye KF. Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1?E9 double transgenic mice. Brain Res. 2011 Feb 28; 1376:94-100.
Score: 0.068
-
Tizabi Y, Hauser SR, Tyler KY, Getachew B, Madani R, Sharma Y, Manaye KF. Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 01; 34(1):62-9.
Score: 0.063
-
Allard JS, Tizabi Y, Shaffery JP, Manaye K. Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression. Neuropeptides. 2007 Oct; 41(5):329-37.
Score: 0.054
-
O'Neil JN, Mouton PR, Tizabi Y, Ottinger MA, Lei DL, Ingram DK, Manaye KF. Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice. J Chem Neuroanat. 2007 Nov; 34(3-4):102-7.
Score: 0.053
-
Rasmussen BA, O'Neil J, Manaye KF, Perry DC, Tizabi Y. Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats. Psychopharmacology (Berl). 2007 Jan; 190(1):43-9.
Score: 0.051
-
Allard JS, Tizabi Y, Shaffery JP, Trouth CO, Manaye K. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides. 2004 Oct; 38(5):311-5.
Score: 0.044
-
LaClair KD, Manaye KF, Lee DL, Allard JS, Savonenko AV, Troncoso JC, Wong PC. Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. Mol Neurodegener. 2013 Jun 13; 8:18.
Score: 0.020
-
Rasmussen BA, Perry DC, O'Neil J, Manaye KF, Tizabi Y. Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism. Neurotox Res. 2008 May-Jun; 13(3-4):151-61.
Score: 0.014